What is SS-31?

SS-31, also referred to as Elamipretide or MTP-131, is a synthetic aromatic-cationic tetrapeptide developed by Hazel Szeto and Peter Schiller – from whose names the “SS” designation is derived. It consists of four amino acids in the sequence D-Arg-2’6′-Dmt-Lys-Phe-NH2, and its unique structural properties allow it to selectively concentrate in the inner mitochondrial membrane at a ratio estimated to be several hundred-fold higher than in other cellular compartments.

This selective mitochondrial targeting is not dependent on mitochondrial membrane potential, which distinguishes SS-31 from many other mitochondria-targeted compounds. This property makes it particularly useful in research settings where mitochondrial membrane potential is compromised – precisely the conditions seen during oxidative stress, ischemia-reperfusion injury, and aging-related mitochondrial dysfunction.

To understand why SS-31 research has attracted so much scientific attention, it is essential to understand cardiolipin and its role in mitochondrial biology. Cardiolipin is a unique phospholipid found almost exclusively in the inner mitochondrial membrane. It plays a structural role in organizing the electron transport chain complexes into supercomplexes – arrangements that significantly enhance the efficiency of ATP production.

Under conditions of oxidative stress, aging, or cellular injury, cardiolipin can become oxidized or redistributed, disrupting the organization of electron transport chain supercomplexes and impairing mitochondrial energy production. This cardiolipin dysfunction is considered a central mechanism in a wide range of conditions studied in preclinical research, including ischemia-reperfusion injury, heart failure models, neurodegenerative research models, and aging biology.

SS-31 research has focused on its ability to bind to cardiolipin and stabilize its interaction with cytochrome c – a key protein in the electron transport chain. By maintaining this interaction, SS-31 is proposed to preserve electron transport chain supercomplex organization and support mitochondrial membrane integrity under stress conditions.

SS-31 research spans multiple biological systems, united by a common thread – mitochondrial dysfunction as an upstream driver of cellular pathology. The following represent the primary pathway areas under active preclinical investigation.

SS-31 occupies a distinct position in the mitochondrial research compound landscape. Its mechanism of action differs significantly from other mitochondria-targeted peptides like MOTS-c and Humanin, which operate primarily through metabolic signaling pathways. Understanding these distinctions helps researchers select the most appropriate compound for their specific investigational framework.

SS-31 has one of the broadest preclinical research profiles of any mitochondria-targeted peptide currently under investigation. The following areas represent the most active and documented research contexts in current peer-reviewed literature.

The inner mitochondrial membrane is one of the most functionally dense structures in cell biology. Packed with the protein complexes of the electron transport chain and ATP synthase, it is the site where the majority of cellular energy is generated. The organization and integrity of this membrane directly determines the efficiency of ATP production and the extent of reactive oxygen species generation.

Research has increasingly recognized that disruption of inner mitochondrial membrane organization – particularly through cardiolipin oxidation and redistribution – is not simply a consequence of cellular stress but an active driver of downstream pathology. This positions mitochondrial membrane integrity as a legitimate research target across a wide range of biological contexts, and SS-31 as one of the most specific and well-characterized tools available for investigating this target in preclinical models.

SS-31 is a tetrapeptide with a specific aromatic-cationic structure that is critical to its mitochondrial targeting properties. Sequence accuracy and stereochemical integrity are therefore particularly important quality considerations when sourcing SS-31 for research use.

SS-31 peptide research represents one of the most mechanistically focused areas of mitochondrial investigation currently underway. By targeting cardiolipin in the inner mitochondrial membrane, SS-31 provides researchers with a precise tool for studying the relationship between mitochondrial membrane integrity, electron transport chain function, and downstream cellular outcomes across a wide range of preclinical research models.

As mitochondrial research continues to expand as a central theme in aging, cardiac, renal, and metabolic biology, SS-31 is likely to remain one of the most actively investigated mitochondria-targeted peptides in the research compound landscape. Researchers sourcing SS-31 for investigational use should prioritize sequence verification, analytical transparency, and independent CoA documentation to ensure experimental integrity.